MedTrace Logo

A Study to Determine the Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Dark Circles

NCT01644448 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-07-25

No results posted yet for this study

Summary

This is a multicentre, open label, randomized, pilot study to evalute safety and efficacy of Human Platelet Lysate (HPL) in subjects with Periorbital Hyperpigmentation. The study is being conducted at 2 centers in India.The primary endpoints are Physicians and Patient Self assessment score. The secondary endpoints are improvement in photographic assessment form randomization to end of study.

Conditions

  • Periorbital Hyperpigmentation (Dark Circles)

Interventions

OTHER

Autologous Human Platelet Lysate

Subjects will receive one dose of 5 ml of HPL with simultaneous micro-needling on day 2

OTHER

Standard Therapy

Topical Applications as directed by the investigator

Sponsors & Collaborators

  • Kasiak Research Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Farida Modi, Dr. · Dermacare

  • Preeti Savardekar, Dr. · Shree Krishna Polyclinic

  • Sharmila Patil, Dr. · Dr. Sharmila's Dermocosmetic laser center, hair and skin clinic

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-10-31
Completion
2012-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644448 on ClinicalTrials.gov